These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Macular dystrophy of the cornea. A histochemical and electron microscopic study. Teng CC Am J Ophthalmol; 1966 Sep; 62(3):436-54. PubMed ID: 4224131 [No Abstract] [Full Text] [Related]
44. Corneal alpha-galactosidase deficiency in macular corneal dystrophy. Bruner WE; Dejak TR; Grossniklaus HE; Stark WJ; Young E Ophthalmic Paediatr Genet; 1985 Apr; 5(3):179-83. PubMed ID: 2999674 [TBL] [Abstract][Full Text] [Related]
45. Cytochemical study of macular dystrophy of the cornea (Groenouw II): an ultrastructural study. Graf B; Pouliquen Y; Frouin MA; Faure JP; Offret G Exp Eye Res; 1974 Feb; 18(2):163-9. PubMed ID: 4133066 [No Abstract] [Full Text] [Related]
46. [Ocular pathology of rhino mouse. II. Histopathology of the cornea--a model of corneal dystrophy (author's transl)]. Yoshida M; Amemiya T; Yoshida H; Kawaji H Nippon Ganka Gakkai Zasshi; 1978 Aug; 82(8):533-9. PubMed ID: 309275 [No Abstract] [Full Text] [Related]
47. Let this be lattice? Dendritiform erosion in lattice dystrophy type I, a source of confusion. Vanlerberghe V; De Craene S; Kestelyn P Int Ophthalmol; 2015 Feb; 35(1):121-3. PubMed ID: 25432880 [No Abstract] [Full Text] [Related]
48. Letter: Granular dystrophy of the cornea. Garner A Am J Ophthalmol; 1974 Nov; 78(5):872-3. PubMed ID: 4138313 [No Abstract] [Full Text] [Related]
49. Macular corneal dystrophy in Saudi Arabia: a study of 56 cases and recognition of a new immunophenotype. Malbran ES Am J Ophthalmol; 1998 Mar; 125(3):417-8. PubMed ID: 9512173 [No Abstract] [Full Text] [Related]
51. Lysosomal storage of sulfated glycosaminoglycans in cultured fibroblasts exposed to immunostimulatory acridine derivatives. Handrock K; Laschke A; Lüllmann-Rauch R; Vogt RD; Ziegenhagen M Toxicol Appl Pharmacol; 1992 Jun; 114(2):204-14. PubMed ID: 1609412 [TBL] [Abstract][Full Text] [Related]
52. Comment on: Characterization of In Vivo Biomechanical Properties in Macular Corneal Dystrophy. Nair S; Kaur M; Titiyal JS Am J Ophthalmol; 2020 Dec; 220():215. PubMed ID: 33097173 [No Abstract] [Full Text] [Related]
53. Reply to Comment on: Characterization of In Vivo Biomechanical Properties in Macular Corneal Dystrophy. Feizi S; Karjou Z; Abbasi H; Javadi MA; Azari AA Am J Ophthalmol; 2020 Dec; 220():215-216. PubMed ID: 33097172 [No Abstract] [Full Text] [Related]
54. Ocular changes in rats in diets deficient in amino acids; corneal dystrophy due to valine deficiency. FERRARO A; ROIZIN L; GIVNER I Arch Ophthal; 1947 Sep; 38(3):342-52. PubMed ID: 20267639 [No Abstract] [Full Text] [Related]
55. Preliminary evaluation of acridine orange as a vital stain for automatic differential leukocyte counts. Melamed MR; Adams LR; Zimring A; Murnick JG; Mayer K Am J Clin Pathol; 1972 Jan; 57(1):95-102. PubMed ID: 4109488 [No Abstract] [Full Text] [Related]
56. The use of acridine orange as a lysosomal marker in rat skeletal muscle. Canonico PG; Bird JW J Cell Biol; 1969 Nov; 43(2):367-71. PubMed ID: 5344154 [No Abstract] [Full Text] [Related]